These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24855722)

  • 1. A different view of the 340B program.
    Chapman R
    Oncology (Williston Park); 2014 Mar; 28(3):178. PubMed ID: 24855722
    [No Abstract]   [Full Text] [Related]  

  • 2. The 340b drug discount program: oncology's optical illusion.
    Eagle D; Buell RL; Vacirca J
    Oncology (Williston Park); 2013 Nov; 27(11):1068, 1070, 1072. PubMed ID: 24575533
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost consequences of the 340B drug discount program.
    Conti RM; Bach PB
    JAMA; 2013 May; 309(19):1995-6. PubMed ID: 23609758
    [No Abstract]   [Full Text] [Related]  

  • 4. 340B Drug Pricing Program: The Expansion and Its Effect on Cancer Care.
    Fauer A; Friese CR
    Clin J Oncol Nurs; 2019 Apr; 23(2):217-219. PubMed ID: 30880808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule.
    Health Resources and Services Administration, Department of Health and Human Services (HHS)
    Fed Regist; 2017 Jan; 82(3):1210-30. PubMed ID: 28071875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the 340B Drug Discount Program in Recent Cancer Care Trends.
    Kantarjian HM; Chapman R
    J Oncol Pract; 2015 Jul; 11(4):303-7. PubMed ID: 26036268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The authors respond.
    Eagle D; Buell R; Vacirca J
    Oncology (Williston Park); 2014 Mar; 28(3):178, C3. PubMed ID: 24855723
    [No Abstract]   [Full Text] [Related]  

  • 8. 340B Drug Pricing Program Reform.
    Fong WH
    JAMA Oncol; 2016 Mar; 2(3):403. PubMed ID: 26967190
    [No Abstract]   [Full Text] [Related]  

  • 9. 340B Drug Pricing Program Reform-Reply.
    Kantarjian H; Chapman R
    JAMA Oncol; 2016 Mar; 2(3):403-4. PubMed ID: 26967191
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of the 340B Drug Discount Program.
    Kantarjian H; Chapman R
    JAMA Oncol; 2015 Nov; 1(8):1029-30. PubMed ID: 26313652
    [No Abstract]   [Full Text] [Related]  

  • 11. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
    American Society of Clinical Oncology
    J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncology Transactions and the 340B Drug Pricing Program.
    Warren A; Shankar A
    J Oncol Pract; 2013 Mar; 9(2):89-91. PubMed ID: 23814516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date.
    Health Resources and Services Administration, HHS
    Fed Regist; 2017 May; 82(96):22893-5. PubMed ID: 28574239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 340B-Where Do We Go From Here?
    Kishore S; Nayak RK; Kesselheim AS
    JAMA; 2023 Aug; 330(7):593-594. PubMed ID: 37505512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date.
    Health Resources and Services Administration, HHS
    Fed Regist; 2017 Sep; 82(188):45511-4. PubMed ID: 28990743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Benefits of the 340b Drug Discount Program.
    Gerlach J; McSweeney S; Swearingen A; Coustasse A
    Health Care Manag (Frederick); 2018; 37(3):225-231. PubMed ID: 29901471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Reach of the 340B Drug Pricing Program.
    Albrecht J; Mudahar S
    JAMA Dermatol; 2015 Sep; 151(9):923-4. PubMed ID: 25993384
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.
    Zeta LM
    Food Drug Law J; 2015; 70(4):481-99, i. PubMed ID: 26827389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change ahead for cancer drug funding.
    Lancet Haematol; 2015 Feb; 2(2):e47. PubMed ID: 26687606
    [No Abstract]   [Full Text] [Related]  

  • 20. US oncologists call for government regulation to curb drug price rises.
    McCarthy M
    BMJ; 2015 Jul; 351():h4063. PubMed ID: 26208848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.